ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01301690
Recruitment Status : Unknown
Verified September 2011 by Li-Jen Liao, Far Eastern Memorial Hospital.
Recruitment status was:  Recruiting
First Posted : February 23, 2011
Last Update Posted : September 19, 2011
Sponsor:
Information provided by (Responsible Party):
Li-Jen Liao, Far Eastern Memorial Hospital

Brief Summary:
3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.

Condition or disease
Neck Mass

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2010

Group/Cohort
Neck masses
Neck mass received US and US-FNA




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
We propose to collect consecutive patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.
Criteria

Inclusion Criteria:

  • patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

Exclusion Criteria:

  • No cytology data

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01301690


Contacts
Contact: Li-Jen Liao, MD +886-0-8967-1592 deniro@mail2000.com.tw

Locations
Taiwan
Department of Otolaryngology Far Eastern Memorial Hospital Recruiting
Taipei, Taiwan
Contact: Shih-Hong Huang, M.D., Ph.D.    +886 0 89671592    irb@mail.femh.org.tw   
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Study Director: Li-Jen Liao, MD Department of Otolaryngology Far Eastern Memorial Hospital, Taipei, Taiwan

Publications:
Responsible Party: Li-Jen Liao, Department of Otolaryngology, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT01301690     History of Changes
Other Study ID Numbers: FEMH No.:98041-3
First Posted: February 23, 2011    Key Record Dates
Last Update Posted: September 19, 2011
Last Verified: September 2011

Keywords provided by Li-Jen Liao, Far Eastern Memorial Hospital:
neck mass
ultrasound
FNA
BMVC